Kangmei Pharma | 600518 - Market Capitalization

Stock Price
1.71
Daily Change
-0.01 -0.58%
Monthly
-2.84%
Yearly
-11.86%
Q2 Forecast
1.69

Kangmei Pharma reported CNY23.85B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Genomma Lab Internacional MXN 18.84B 719.4M Apr/2026
Hypermarcas BRL 14.92B 706.02M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 29.18B 9.2B Apr/2026
Jiangsu Hengrui CNY 360.41B 6.49B Apr/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Wuxi Apptec CNY 269.45B 61.09B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zz Pientze Pharmaceu CNY 86.94B 31.78B Apr/2026